 | ENDRA Life Sciences Inc. | |||
| NCM : NDRA || Location: United States | ||||
$0.24-0.02 (-6.73%) |
0.04 M | 0.23 - 0.26 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.008 M |
| March 28, 2024 | 0.031 M |
| March 15, 2024 | 0.048 M |
| Feb. 29, 2024 | 0.055 M |
| Feb. 15, 2024 | 0.029 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.37 | -0.05 | 86.38% |
| 09/30/2023 | -0.44 | -0.40 | 8.80% |
| 06/30/2023 | -0.56 | -0.43 | 23.35% |
| 03/31/2023 | -1.07 | -0.93 | 12.75% |
| 12/31/2022 | -0.90 | -0.96 | -6.70% |
NDRA Basic Data
| Sector | Healthcare | Industry | Diagnostics & Research |
| Shares Outstanding | 11.036M | Shares Float | 10.685M |
| Short Float | 0.008M | Market Cap | 2.87M |
| Institution ownership | 1.18% | Insider ownership | 3.153% |
| Earnings Date | 05/13/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.58 | Forward EPS | -1.41 |